What are the available shipping terms?

We offer FOB, CFR, CIF, CIP, and EXW.

Where is the company located?

The company is located at Shimen Mansion, No. 1, Siyao Road, Economic & Development Zone, Shijiazhuang, Hebei, China.

Azithromycin Plant CAS 83905-01-5

Name: Azithromycin Plant CAS 83905-01-5
Brand: Shijiazhuang No. 4 Pharmaceutical Co., Ltd.
SKU: 905242735

Hebei, ChinaShijiazhuang No. 4 Pharmaceutical Co., Ltd.

US$10.00-500.00

2,000 kg

Sample price:US$1.00/piece.Request sample

Product profile

Customization

Available

Production Line

GMP Approved

Transport Package

Drum

Model NO.

pharmaceutical use

Specification

25kg/drum

Trademark

SHIMEN

Origin

Hebei

Production Capacity

10000ton

Key features

GMP Approved Production: Manufactured on a GMP approved production line ensuring high quality standards.

Global Market Reach: Products exported to over 80 countries and regions worldwide.

Established Manufacturer: SSY Group established in 1948 with over 70 years of development history.

Advanced Production Tech: Intelligent continuous production replacing traditional intermittent methods.

Comprehensive Product Range: Includes APIs, tablets, capsules, injections, and medical packaging materials.

Large Scale Enterprise: Super-large pharmaceutical enterprise with 3 billion RMB investment.

Flexible Payment Terms: Accepts LC and T/T for international transactions.

Multiple Incoterms: Supports FOB, CFR, CIF, CIP, and EXW shipping terms.

Company profile

Shijiazhuang No. 4 Pharmaceutical Co., Ltd.

Hebei, China

Business Type: Manufacturer/FactoryExport Year: 2002-01-01Nearest Port: Tianjin Xingang, Qingdao, ShanghaiAverage Response Time: ≤15hTerms of Payment: LC, T/TInternational Commercial Terms(Incoterms): FOB, CFR, CIF, CIP, EXW

AI-Powered supplier vetting

SummaryShijiazhuang No. 4 Pharmaceutical Co., Ltd. is identified as a Chinese public pharmaceutical manufacturer based in Hebei, with products spanning infusion solutions, injections, tablets, capsules, inhalation products, and other medical materials. The supplier reports ISO 9001, ISO 14001, and GMP certifications, more than ten production lines, automated and information-based production and logistics processes, and substantial stated output across several dosage forms. Its export activity began in 2002, although exports represent only 1%–10% of total sales. The company describes integrated R&D, manufacturing, and marketing capabilities, but the provided information does not establish specific after-sales programs, customization services, or named customer cases. Financial strength cannot be assessed because financial data is excluded.

Supplier typeThe supplier is explicitly classified as a Manufacturer/Factory and is described as an integrated pharmaceutical enterprise covering R&D, industrial production, and marketing. Its listed business covers health and medicine products, including injections, infusion solutions, tablets, capsules, and related dosage forms.

CertificationsThe supplier reports ISO 9001, ISO 14001, and GMP certifications. It also states that production is organized strictly according to GMP requirements, providing explicit evidence of formal quality, environmental, and pharmaceutical manufacturing systems.

R&D capabilityThe supplier describes an integrated R&D, production, and marketing model, reports 50 R&D engineers, and states that its production lines integrate leading equipment and technology at an international advanced level. This supports established technical and development capability, although no specific patents, new-product results, or R&D investment details are provided.

Production capacityProduction capability is strongly supported by more than ten production lines, automated and information-based production and logistics processes, and stated annual outputs of 1.5 billion large-volume injection units and 1 billion units each for tablets, capsules, and small-volume injections. The company also reports more than ten international advanced infusion-solution lines and exports through both agency and self-operated channels.